TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← Back to TickerSpark
▌IPO·November 11, 2026

ANTHROPIC, PBC IPO: What to Know Before It Lists

Anthropic, PBC is expected to list on NASDAQ on 2026-11-19 in an IPO priced at $70.00 to $78.00 per share. The company has not disclosed a market cap in the calendar data, but its filing shows a massive revenue base and equally massive losses. The bull case is enterprise AI adoption; the bear case is whether competition, regulation, and spending intensity can keep pace with growth.

IPOIPONASDAQANT
By TickerSpark·November 11, 2026·6 min read
ANTHROPIC, PBC IPO: What to Know Before It Lists
▌Key Takeaway
Anthropic, PBC is expected to list on NASDAQ on 2026-11-19 in an IPO priced at $70.00 to $78.00 per share. The company has not disclosed a market cap in the calendar data, but its filing shows a massive revenue base and equally massive losses. The bull case is enterprise AI adoption; the bear case is whether competition, regulation, and spending intensity can keep pace with growth.

Quick Facts

Expected listing date: November 19, 2026

Exchange: NASDAQ

Proposed symbol: ANT

Price range: 70.00 - 78.00

Shares offered: 825.00M shares

Status: Expected

Company Overview

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Anthropic, PBC is a San Francisco-based public benefit corporation founded in January 2021 around the responsible development of advanced AI. Its flagship product is Claude, which it delivers through models, a platform, and applications for enterprise customers. The filing highlights use cases ranging from routine knowledge work to complex tasks, including Claude Code for software development and Claude Cowork for knowledge work. Anthropic says much of Claude’s adoption has been organic, then amplified through direct go-to-market and Applied AI teams.

The company’s customer base has expanded quickly. Anthropic says customers with $100,000+ in trailing-12-month revenue grew from about 20 at year-end 2023 to about 200 at year-end 2024, 1,500 at year-end 2025, and more than 11,900 as of September 30, 2026. It also says it had more than 1,900 customers with $1 million+ in trailing-12-month revenue and about 250 customers with $10 million+ as of September 30, 2026, with over 50% of the Fortune 500 and over 30% of the Global 2000 represented among customers at the $100,000+ level.

Anthropic is competing in a fast-moving frontier-model market where scale, distribution, and compute access matter as much as product quality. The filing frames the opportunity as expanding as Claude unlocks new workflows, while the broader AI market remains crowded with well-capitalized rivals and rapidly changing regulation. That makes this IPO less about a single product launch and more about whether Anthropic can convert model leadership into durable enterprise spending.

Why They're Going Public

Anthropic says IPO proceeds will go toward general corporate purposes, including working capital, operating expenses, and capital expenditures, especially compute and infrastructure. The filing also points to hiring and retention as a use of proceeds, which fits a business that is still scaling its research, product, and go-to-market footprint.

The listing also gives Anthropic more flexibility for acquisitions or investments, although it says it has no material acquisition commitments at this time. A portion of proceeds is earmarked for tax withholding and remittance obligations tied to RSU settlement, so the offering is not just about growth capital; it also supports the company’s equity compensation structure as it scales.

Get AI research on any stock

Instant reports, daily intelligence, and an AI analyst in your pocket.

Get Started →

Financial Highlights

Anthropic’s top line has moved from $41 million in 2023 to $386 million in 2024, then to $4.6 billion in 2025. For the nine months ended September 30, 2026, revenue reached $33.2 billion, and the filing says trailing-12-month revenue was $35.4 billion. The mix is still heavily consumption-driven: consumption revenue rose from $288 million in 2024 to $3.8 billion in 2025 and $26.3 billion in the first nine months of 2026, while subscription revenue increased from $98 million to $789 million to $6.9 billion over the same periods.

Profitability is the clear pressure point. Anthropic reported net losses of $1.531 billion in 2023, $8.309 billion in 2024, $41.965 billion in 2025, and $104.039 billion for the nine months ended September 30, 2026. Even so, the balance sheet is unusually strong for a company at this stage: as of September 30, 2026, it reported $95.562 billion of cash and cash equivalents and $98.152 billion of cash, cash equivalents, and restricted cash at period end. That gives it substantial runway, but the filing also notes revenue growth may slow as the base gets larger.

Risk Factors

The biggest risk is competition. Anthropic says the market is intensely competitive and that better-capitalized rivals can outspend or out-distribute it. That matters because AI model economics can shift quickly, and the company’s ability to keep customers engaged depends on continued product performance, pricing power, and distribution.

Regulation is another major overhang. The filing calls out rapidly evolving rules around AI, privacy, data protection, export controls, sanctions, and government procurement. Anthropic also has a limited operating history under its current go-to-market model, which makes retention and expansion harder to forecast. Customer concentration and platform dependence add another layer of risk, since customers may reduce reliance on Anthropic or even compete with it. The company’s public benefit corporation structure and controlled-company status also mean governance may not always align with short-term financial priorities.

Investors should also watch dilution and lockup dynamics. The filing shows a standard 180-day lock-up for many shares, with some 365-day lock-ups, but it does not cleanly disclose a final public float number in the excerpts reviewed. With 825,000,000 shares offered in the IPO calendar data, the size of the deal itself will be a key factor in how the stock trades after listing.

Comparable Public Companies

A practical comp set includes Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN), and Meta Platforms (META), since all four are major public AI beneficiaries with the scale to fund model development, cloud infrastructure, and enterprise distribution. Anthropic is not a direct public peer in the same way, but these names help frame the market’s willingness to pay for AI exposure and the premium investors assign to companies with durable cash generation.

Relative to those giants, Anthropic is earlier, smaller in public-market terms, and far more loss-making, but its revenue growth is much faster on a percentage basis. The filing’s $35.4 billion trailing-12-month revenue figure would put it in a very different league from most recent AI IPOs, though the losses are also extreme. That makes the comparison less about current earnings and more about whether investors believe Anthropic can sustain enterprise demand and eventually turn model usage into durable margin.

The broader AI trade has remained active, but public-market sentiment has been mixed rather than uniformly euphoric. Mega-cap AI names have generally benefited from the theme, while smaller AI software and infrastructure names have tended to trade on execution and monetization proof. For Anthropic, that means the sector backdrop is favorable, but the market will likely focus on pricing discipline and whether the IPO comes at a level that leaves room for post-listing upside.

Verdict

This is a high-profile AI listing with real scale, but the key question is not whether Anthropic has momentum; it clearly does. The question is whether the IPO price reflects a business that is still spending heavily, still posting very large losses, and still operating in a market where competition and regulation can change the economics quickly. Shareholders should watch the final pricing range, the implied valuation versus the company’s $35.4 billion trailing-12-month revenue, and how much float actually comes to market.

The timing angle is straightforward: AI remains one of the market’s strongest narratives, and Anthropic is arriving as enterprise demand for coding and knowledge-work automation is still expanding. That makes the deal noteworthy right now, especially because the company has already built a large customer base and a massive revenue run rate. The setup favors close attention to how the market values growth versus durability when the stock starts trading on NASDAQ.

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌For Active Investors

Don't trade alone.

Get market intelligence delivered daily.

Get Full Access →

Not ready to subscribe? ·

▌For Active Investors

Stock research for every investor

  • Reports on any stock
  • Daily market intelligence
  • AI analyst in your pocket
  • Portfolio analysis tools
Get Full Access →

Cancel anytime

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌Keep reading

More to read

All articles
Should You Buy the Tracx Logis IPO? Here's the Setup
TRCX

Should You Buy the Tracx Logis IPO? Here's the Setup

Tracx Logis Ltd. (NASDAQ: TRCX) is expected to list on 2026-11-13, with shares priced at $18.00 to $22.00. The offering is 1,000,000 shares. The setup is interesting because the company has real revenue scale, but the filing also shows heavy leverage, negative equity, and a resale-heavy structure.

Nov 11·6 min
Modern Mining Technology Corp. Turns E-Waste Into Metals: IPO Watch
MDRN

Modern Mining Technology Corp. Turns E-Waste Into Metals: IPO Watch

Modern Mining Technology Corp. is expected to list on the NYSE on 2026-11-13, but the price range has not been disclosed yet. The company is pitching a landfill-to-commodity model tied to E-waste recovery and metal refining. The setup is intriguing for the circular-economy story, but shareholders should watch the lack of revenue, the going-concern warning, and whether it can secure feedstock and customers.

Nov 11·6 min
Windward Bio IPO: The Bull and Bear Case for WWB
WWB

Windward Bio IPO: The Bull and Bear Case for WWB

Windward Bio Group AG (Nasdaq: WWB) is expected to list on 2026-11-13 at a price range of $16.00 to $18.00 per share. The biotech is betting that ultra-long-acting antibody drugs can win in asthma, COPD, and atopic dermatitis. The bull case is a large respiratory-immunology market and a cash-rich balance sheet; the bear case is that Windward has no approved products and still needs clinical execution to prove its lead programs.

Nov 10·5 min